PMID- 26907482 OWN - NLM STAT- MEDLINE DCOM- 20170109 LR - 20181202 IS - 2233-6869 (Electronic) IS - 1598-9992 (Linking) VI - 67 IP - 2 DP - 2016 Feb TI - [Comparison on Oral versus Intravenous Proton Pump Inhibitors for Prevention of Bleeding after Endoscopic Submucosal Dissection of Gastric Lesions]. PG - 74-80 LID - 10.4166/kjg.2016.67.2.74 [doi] AB - BACKGROUND/AIMS: Although intravenous proton pump inhibitor (PPI) has been used for the prevention of post endoscopic submucosal dissection (ESD) bleeding, the route of administration has not been confirmed. The aim of the present study was to compare the efficacy of intravenous and oral PPI administration for the prevention of delayed post ESD bleeding. METHODS: Total 166 consecutive patients were randomly assigned to 30 mg lansoprazol twice a day (PO group) and 120 mg pantoprazole intravenous injection (IV group) for 48 hours. Finally, 65 patients in PO group and 87 patients in IV group were analyzed. After ESD, all patients underwent follow up endoscopy after 24 hours and were observed the symptoms of bleeding up to 60 days after ESD. RESULTS: Age, sex and use of anticoagulants were not different between groups. At follow up endoscopy after 24 hours, oozing and exposed vessel was noted in 4.6% of PO group and 8.0% of IV group and there was no significant difference. Delayed bleeding occurred in 4 of 65 patients (6.2%) in the PO group and 8 of 87 patients (9.2%) in the IV group (p>0.999). By multivariate analysis, oozing or exposed vessels at follow up endoscopy were risk factors for delayed bleeding (OR=17.5, p=0.022). CONCLUSIONS: There was no significant difference in the delayed bleeding, length of hospital stay according to the administration route. Bleeding stigmata at follow up endoscopy was risk factor of delayed bleeding. Oral PPI administration can cost-effectively replace IV PPI for prevention of post ESD bleeding. FAU - Jung, Yeoun Su AU - Jung YS AD - Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea. FAU - Kim, Kyeong Ok AU - Kim KO AD - Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea. FAU - Lee, Si Hyung AU - Lee SH AD - Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea. FAU - Jang, Byung Ik AU - Jang BI AD - Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea. FAU - Kim, Tae Nyeun AU - Kim TN AD - Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea. LA - kor PT - Comparative Study PT - Journal Article PT - Randomized Controlled Trial PL - Korea (South) TA - Korean J Gastroenterol JT - The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi JID - 101189416 RN - 0 (2-Pyridinylmethylsulfinylbenzimidazoles) RN - 0 (Anticoagulants) RN - 0 (Proton Pump Inhibitors) RN - 0K5C5T2QPG (Lansoprazole) RN - D8TST4O562 (Pantoprazole) SB - IM MH - 2-Pyridinylmethylsulfinylbenzimidazoles/therapeutic use MH - *Administration, Oral MH - Aged MH - Anticoagulants/therapeutic use MH - Endoscopic Mucosal Resection/*adverse effects MH - Female MH - Gastroscopy MH - Humans MH - *Injections, Intravenous MH - Lansoprazole/therapeutic use MH - Male MH - Middle Aged MH - Odds Ratio MH - Pantoprazole MH - Postoperative Hemorrhage/etiology/*prevention & control MH - Prospective Studies MH - Proton Pump Inhibitors/*therapeutic use MH - Risk Factors MH - Stomach Neoplasms/surgery OTO - NOTNLM OT - Endoscopic submucosal dissection OT - Hemorrhage OT - Proton pump inhibitors EDAT- 2016/02/26 06:00 MHDA- 2017/01/10 06:00 CRDT- 2016/02/25 06:00 PHST- 2016/02/25 06:00 [entrez] PHST- 2016/02/26 06:00 [pubmed] PHST- 2017/01/10 06:00 [medline] AID - 10.4166kjg.2016.67.2.74 [pii] AID - 10.4166/kjg.2016.67.2.74 [doi] PST - ppublish SO - Korean J Gastroenterol. 2016 Feb;67(2):74-80. doi: 10.4166/kjg.2016.67.2.74.